The Reflex Study: Prevention of Joint Structural Damage at 1 Year with Rituximab in Rheumatoid Arthritis Patients with an Inadequate Response to One or More TNF Inhibitors
The Reflex Study: Prevention of Joint Structural Damage at 1 Year with Rituximab in Rheumatoid Arthritis Patients with an Inadequate Response to One or More TNF Inhibitors
The Reflex Study: Prevention of Joint Structural Damage at 1 Year with Rituximab in Rheumatoid Arthritis Patients with an Inadequate Response to One or More TNF Inhibitors